Portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 2 
Published in Journal 1, 2015
This paper is about the number 3. The number 4 is left for future work.
Recommended citation: Your Name, You. (2015). "Paper Title Number 3." Journal 1. 1(3).
Download Paper | Download Slides
Published in Cancers, 2021
Correct identification of subjects at high risk is critical in the prevention and early screening of prostate cancer (PCa). Analysis of metabolites in biofluids has shown to be a promising method to identify novel PCa biomarkers. To identify potential biomarkers of PCa, we conducted metabolic profiling of pre-diagnosis plasma metabolite profiles from a large prospective male cohort (n = 418), which included 146 males who developed PCa during a 13-year follow-up and 272 matched controls to investigate the relationship with long-term PCa risk. We show metabolite profiles discriminate males who subsequently developed PCa during the follow-up from matched controls with a high degree of accuracy (AU-ROC 0.92) and highlight 10 metabolites associated with a high risk of PCa. These results suggest that the dysregulation of amino acids and sphingolipid metabolism is associated with future risk of PCa.
Recommended citation: Lin X, Lécuyer L, Liu X, Triba MN, Deschasaux-Tanguy M, Demidem A, Liu Z, Palama T, Rossary A, Vasson MP, Hercberg S, Galan P, Savarin P, Xu G, Touvier M. Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry. Cancers (Basel). 2021 Jun 23;13(13):3140. doi: 10.3390/cancers13133140.
Download Paper
Published in Metabolites, 2022
The objectives of our study were three-fold: (1) describe the relative plasma metabolome and lipidome changes in ST and NASH compared to health control (HC) obese patients; (2) investigate whether plasma metabolomic and lipidomic analysis could help to uncover potential metabolic markers or metabolic pathways associated with MAFLD, if any; (3) identify clinical, metabolomic and lipidomic patterns associated with the disease with the help of a computational multiblock omics framework.
Published in GitHub Journal of Bugs, 2024
This paper is about fixing template issue #693.
Recommended citation: Your Name, You. (2024). "Paper Title Number 3." GitHub Journal of Bugs. 1(3).
Download Paper
Published in GitHub Journal of Bugs, 2024
This paper is about a famous math equation, \(E=mc^2\)
Recommended citation: Your Name, You. (2024). "Paper Title Number 3." GitHub Journal of Bugs. 1(3).
Download Paper
Published:
This is a description of your talk, which is a markdown file that can be all markdown-ified like any other post. Yay markdown!
Published:
This is a description of your conference proceedings talk, note the different field in type. You can put anything in this field.
Workshop, University 1, Department, 2015
This is a description of a teaching experience. You can use markdown like any other post.
Undergraduate course, University of Oulu, Faculty of Medicine, 2026